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Background: Synthetic L-ascorbic acid (vitamin C) is widely used as a preservative and nutrient in food and
pharmaceutical industries. In the current production method, D-glucose is converted to L-ascorbic acid via several
biochemical and chemical steps. The main source of L-ascorbic acid in human nutrition is plants. Several alternative
metabolic pathways for L-ascorbic acid biosynthesis are known in plants. In one of them, D-galacturonic acid is the
precursor. D-Galacturonic acid is also the main monomer in pectin, a plant cell wall polysaccharide. Pectin is abundant
in biomass and is readily available from several waste streams from fruit and sugar processing industries.
Results: In the present work, we engineered the filamentous fungus Aspergillus niger for the conversion of
D-galacturonic acid to L-ascorbic acid. In the generated pathway, the native D-galacturonate reductase activity was
utilized while the gene coding for the second enzyme in the fungal D-galacturonic acid pathway, an L-galactonate
consuming dehydratase, was deleted. Two heterologous genes coding for enzymes from the plant L-ascorbic acid
pathway – L-galactono-1,4-lactone lactonase from Euglena gracilis (EgALase) and L-galactono-1,4-lactone
dehydrogenase from Malpighia glabra (MgGALDH) – were introduced into the A. niger strain. Alternatively, an
unspecific L-gulono-1,4-lactone lactonase (smp30) from the animal L-ascorbic acid pathway was introduced in
the fungal strain instead of the plant L-galactono-1,4-lactone lactonase. In addition, a strain with the production
pathway inducible with D-galacturonic acid was generated by using a bidirectional and D-galacturonic acid
inducible promoter from the fungus. Even though, the lactonase enzyme activity was not observed in the
resulting strains, they were capable of producing L-ascorbic acid from pure D-galacturonic acid or pectin-rich
biomass in a consolidated bioprocess. Product titers up to 170 mg/l were achieved.
Conclusions: In the current study, an L-ascorbic acid pathway using D-galacturonic acid as a precursor was
introduced to a microorganism for the first time. This is also the first report on an engineered filamentous
fungus for L-ascorbic acid production and a proof-of-concept of consolidated bioprocess for the production.
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L-Ascorbic acid (L-AA), also known as vitamin C, is a
six-carbon organic compound with reducing agent prop-
erties. It occurs naturally in many animal and plant cells
having biological functions, such as being an antioxidant
and enzyme cofactor [1,2]. Synthetic L-AA is commer-
cially used for several purposes in food, beverage, feed* Correspondence: joosu.kuivanen@vtt.fi
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unless otherwise stated.and pharmaceutical industries. The annual production
of synthetic L-AA is about 110 000 tonnes with the fluc-
tuating market price of about 10 USD per kg [3].
Industrial L-AA production has been traditionally based
on the Reichstein process which is an efficient multi-step
and mostly chemical manufacturing method converting
D-glucose to L-AA [4]. In the first step, D-glucose is hy-
drogenated to D-sorbitol followed by the oxidation of D-
sorbitol to L-sorbose that is commonly carried out using a
bacterial fermentation [3]. The resulting L-sorbose is then
chemically oxidized to 2-keto-L-gulonate and lactonizedal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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steps have focused on the microbial conversion of D-
sorbitol, L-sorbose or D-glucose to 2-keto-L-gulonic acid
that is the last intermediate in the Reichstein process [5].
Currently, the predominant industrial process for L-AA
production is a so called two-step fermentation process
[3]. In the first step, D-sorbitol is oxidized to L-sorbose
using Gluconobacter oxydans. The second step is a mixed
fermentation with Ketogulonicigenium vulgare and Bacil-
lus megaterium, converting L-sorbose to 2-keto-L-gulonic
acid which is then chemically converted to L-AA.
In addition to the partially biotechnological processes,
some approaches using wild type or engineered microbes
for the direct L-AA production have been reported in the
literature. A one-step process from biomass sugar to L-
AA would be advantageous when compared to the cur-
rently used two-step fermentation process. Yeast have a
native biosynthetic pathway for D-erythroascorbic acid
(D-EA), a 5-carbon analogue of L-AA, where D-arabinose
is converted to D-EA via D-arabino-1,4-lactone [6]. The
D-EA pathway seems to be relatively unspecific converting
also L-galactose and L-galactono-1,4-lactone (L-galL) to
L-AA [7,8]. The reactions are similar to the reactions of L-
AA synthesis in plants via the Smirnoff-Wheeler (S-W)
pathway. In addition to yeast, a strain of K. vulgare, the
bacterium that is used in the two-step fermentation
process, is capable of converting D-sorbitol, L-sorbose, L-
sorbosone and L-gulose directly to L-AA [9]. Also several
strains of algae producing small concentrations of extra-
cellular L-AA have been reported in the literature [10].
In the field of metabolic engineering, there are a few at-
tempts to introduce the plant S-W pathway to yeast either
by overexpressing the native substrate-unspecific D-EA
pathway genes or expressing the S-W pathway genes from
Arabidopsis thaliana. The resulting strains were capable
of converting L-galactose, D-glucose and D-galactose to
L-AA [11-13]. The product titers were reported to be
about 100 mg l−1 from L-galactose [11], 0.1 mg l−1 OD−1
from D-glucose [12] and 30 mg l−1 from D-galactose [13].
In plants, L-AA is considered to be synthesized pre-
dominantly through the S-W pathway where D-glucose
is converted via GPD-D-mannose and L-galactose to L-
galL which is oxidized to L-AA in the final step by the
L-galL dehydrogenase (GALDH) [14]. In addition to S-
W, a few alternative pathways for L-AA synthesis have
been observed in plants. One of them originates from
D-galacturonic acid (D-galUA) which is reduced to L-
galactonic acid (L-galA) and further lactonized to L-
galL, which is the last intermediate in the S-W pathway
[1]. Even though the function of a D-galUA reductase
for L-AA biosynthesis was shown in higher plants [15],
the evidence of the pathway converting D-galUA to L-
AA is still incomplete – the gene coding for an L-galL
aldonolactonase (ALase) catalysing the lactonization ofL-galA to L-galL has been described only in the photo-
synthetic organism Euglina gracilis [16]. This activity
was however found in animals as part of the biosyn-
thetic L-AA pathway. In the animal pathway, L-gulonic
acid is lactonized to its corresponding 1,4-lactone by an
ALase that is encoded by the smp30 gene. The enzyme
is unspecific and can also catalyse the lactonization of
L-galA [17].
In the present study, instead of using the plant S-W
pathway for L-AA synthesis, we have focused on the alter-
native pathway converting D-galUA to L-AA. D-GalUA is
the main monomer in pectin, a heteropolysaccharide
found from plant cell walls, which is especially abundant
in some non-woody biomass types, such as citrus fruit
peels and sugar beet pulp. Both of these materials are
abundantly available as agro-industrial side streams. The
enzymes for degradation of pectin to D-galUA the cata-
bolic pathways for its utilization are known in many mi-
crobial organisms. In fungi, such as Aspergillus niger, the
pathway for D-galUA catabolism is reductive having a
similar reduction step from D-galUA to L-galA as in the
L-AA synthesis pathway originating from D-galUA in
plants (Figure 1) [18]. Previously, we reported engineered
A. niger strains capable of converting pure D-galUA and
citrus processing waste (CPW) to L-galA that can be
chemically converted to L-AA [19,20]. In the present
study, we have engineered A. niger strains that are capable
of direct production of L-AA from D-galUA and CPW.
Results
Pathway assembly and transcription
The fungal catabolic D-galUA pathway and the proposed
D-galUA originating biosynthetic L-AA pathway in plants
share the same reduction step yielding L-galA in the first
reaction (Figure 1). Thus, the A. niger strain ΔgaaB with
the disrupted L-galA dehydratase gene, which is known to
accumulate L-galA, was used as a platform strain. In
addition, two heterologous genes from the plant or animal
L-AA pathway, an ALase and a GALDH, were introduced
to the strain. Several different A. niger ΔgaaB based strains
with an ALase (EgALase or smp30) and a GALDH
(MgGALDH) or only the GALDH were generated and
tested (Table 1). The MgGALDH gene that was used con-
tained its native mitochondrial signal peptide region at the
beginning of the ORF. In addition, a constitutive (PgpdA)
and a D-galUA inducible (PgaaA/C) promoter were
compared.
To avoid unnecessary and energy wasting expression
of the L-AA pathway genes in non-producing condi-
tions, the strain ΔgaaB-Eg-Mg (PgaaA/C) with D-galUA
inducible EgALase and MgGALDH expression was gen-
erated using the bidirectional gaaA/C promoter. Since
there are no reports on the use of gaaA/C promoter in
heterologous expression, the functionality of the D-
Figure 1 Schematic figure of the disrupted fungal D-galUA pathway and the heterologous pathway introduced in A. niger for L-AA
biosynthesis: native GaaA (D-galUA reductase), native GaaB (L-galA dehydratase), EgALase (L-galL aldonolactonase from Euglena
gracilis), Smp30 (aldonolactonase from rat functioning in the animal L-AA pathway) and MgGALDH (L-galL dehydrogenase from
Malpighia glabra).
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from the gaaA/C promoter was tested using RT-qPCR
(Figure 2). The transcription of both of the heterologous
genes was clearly induced at 20 hours after the shift to D-
galUA containing medium. The pattern of MgGALDH
transcription was similar to the transcription of the native
gaaA gene, which was expected since MgGALDH was ori-
entated in the same way behind the bidirectional gaaA/C
promoter as the gaaA gene is. The transcription of EgA-
Lase was higher when compared to gaaA and MgGALDH
after the D-galUA induction. A similar observation was
reported earlier in the case of native gaaC gene (2-keto-3-
deoxy-L-galactonate aldolase) which had a higher tran-
scription when compared to gaaA growing in D-galUA
medium [21]. EgALase had the same orientation at gaaA/
C promoter as gaaC gene in the wild type strain.Table 1 Plasmids and A. niger strains used in this work
Plasmid Genes expressed
JKp1-EgALase The codon optimized Euglina gracilis Alase (Eg
[GenBank: AB306917]
JKp1-Smp30 The codon optimized rat Smp30 [GenBank: CA
JKp1-MgGALDH The codon optimized Malpighia glabra GALDH
(MgGALDH) [GenBank: ACG75919] ORF




ΔgaaB-Eg-Mg (PgpdA) EgALase and MgGALDH
ΔgaaB-Smp30-Mg Smp30 and MgGALDH
ΔgaaB-Eg-Mg (PgaaA/C) EgALase and MgGALDHEnzyme activities
Enzyme activities of the introduced L-AA pathway genes
were measured from crude extracts. The GALDH activ-
ity assay was based on the measurement of reduced
cytochrome C as a result from oxidation of L-galL. The
activity was tested from the parental strain ΔgaaB and
from the further engineered strains that were cultured
20 h in the medium supplemented with 20 g l−1 D-
galUA and 5 g l−1 D-xylose (Figure 3). All the strains
with MgGALDH under the constitutive gpdA promoter
showed the activity for L-galL while only residual activ-
ity was found from the parental strain ΔgaaB. In the
case of ΔgaaB-Eg-Mg (PgaaA/C) strain, the GALDH ac-
tivity was lower; however, it was still significantly higher







ATCC 1015 with the deleted L-GalA dehydratase gene gaaB
ΔgaaB with MgGALDH expressed under gpdA promoter
ΔgaaB with EgALase and MgGALDH, both expressed
under gpdA promoter
ΔgaaB with Smp30 and MgGALDH, both expressed
under gpdA promoter
ΔgaaB with EgALase and MgGALDH, both expressed
under bidirectional gaaA/C promoter
Figure 2 The D-galUA inducible expression cassette and relative
transcription of gaaA (blue squares), EgALase (red triangles) and
MgGALDH (green circles) in the strain ΔgaaB-Eg-Mg (PgaaA/C)
after the shift from pre-cultures to medium supplemented with
D-galUA and D-xylose. Values were normalized to the expression
of actin. Error bars represent ± SEM (n = 3).
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lysed by an ALase, protons are absorbed in an equimolar
manner increasing the pH in the reaction. The relation
between absorption at 405 nm and proton concentration
was quantified being ΔA405 = 0.003 per 10 μM of pro-
tons which should provide high enough sensitivity for
the ALase assay. We tested all the engineered strains forFigure 3 GALDH activity for L-galL from the crude extracts of
ΔgaaB, ΔgaaB-Mg ΔgaaB-Eg-Mg (PgpdA), ΔgaaB-Eg-Mg (PgaaA/C)
and ΔgaaB-Smp30-Mg cultured in minimal medium
supplemented with D-galUA and D-xylose for 20 h. All of the
values from the strains with introduced MgGALDH differed significantly
from the value from ΔgaaB (P < 0.05, Student’s t-test). Error bars
represent ± SEM (n = 3).ALase activity in the presence of L-galA; however, we
could not detect this activity.
Production of L-AA
The parental strain ΔgaaB and the different engineered
strains were tested for L-AA production even though
the lactonase activities were not detectable. We used
flask cultures on defined medium supplemented with D-
galUA and D-xylose and with the initial pH adjusted to
3.0. With the strain ΔgaaB only L-AA concentrations of
below 3.5 mg l−1 were observed in the cultures (Figure 4).
All the engineered strains having MgGALDH under
gpdA or gaaA/C promoter produced L-AA at concentra-
tions of around 55–83 mg l−1. Also the strain ΔgaaB-Mg
without an ALase produced similar L-AA concentrations
as the strain ΔgaaB-Eg-Mg (PgpdA) with the introduced
EgALase gene. In fact, the L-AA production corresponds
to the GALDH activity in the strains having MgGALDH
under PgpdA (Figure 3). The clearest difference between
the engineered strains was the timing of the highest L-
AA concentration in the medium – all the strains with
MgGALDH under gpdA promoter had the highest titer
at 48 h whereas ΔgaaB-Eg-Mg (PgaaA/C) had the high-
est titer at 96 h. The decreasing L-AA concentrations
during the time course may be due to the instability of
the product causing by the exposure to air. In addition,
the production turned out to be pH dependent since L-
AA production was not observed when the initial pH
was 5.0 (data not shown).
Even though, D-xylose was used as a co-substrate, one
of the reasons for limited L-AA production may be the
lack of NADPH for the D-galUA reductase gaaA in the
first reaction in the pathway. In addition, energy and
carbon sources are needed for the expression of heterol-
ogous L-AA pathway genes. To overcome these possibleFigure 4 L-Ascorbate production by engineered A. niger strains
in minimal medium supplemented with D-galUA and D-xylose.
Error bars represent ± SEM (n = 3).
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rich residue, we used CPW as substrate containing a
complex mix of different sugars and sugar acids in the
form of polysaccharides. We decided to use ΔgaaB-Eg-
Mg (PgaaA/C) strain in order to avoid unnecessary and
energy wasting expression of the heterologous genes at
the beginning of fermentation when free D-galUA is not
yet available. In addition, we used higher fungal biomass
in the inoculation in order to ensure CPW hydrolysis and
speed up the process. L-AA production from CPW turned
out to be more efficient than in defined media conditions
with respect to the final concentrations (Figure 5). A lag
phase of about 48 h was observed before the production
started at a higher rate, which is probably due to rather
slow pectin hydrolysis to D-galUA and utilization of the
more preferred carbon sources, such as D-glucose present
in CPW. The D-galUA content in CPW that was prepared
as the CPW used in this study was reported to be 27% on
a dry mass basis [20]. Other detected main components
after pectinase hydrolysis were L-arabinose, D-galactose,
D-glucose and L-rhamnose. Even though, L-AA produc-
tion started later than when compared to the defined con-
ditions with the ΔgaaB-Eg-Mg (PgaaA/C) strain the
highest titer (around 170 mg l−1) was achieved at 96 h as
was the case of the cultures in the defined conditions. As
in the case of defined conditions, a decrease in L-AA con-
centration was observed after 96 h probably due to the in-
stability of the product. The CPW used as a substrate did
not contain detectable amounts of L-AA. In the control
fermentations with the parental strain ΔgaaB, the ob-
served L-AA concentrations were below 15 mg l−1.
Discussion
Synthetic L-AA is a widely used compound in several in-
dustries. Currently it is produced in a multistep processFigure 5 Concentration of extracellular L-ascorbate (green
squares), D-galUA (red triangles) and L-galA (blue circles) from
a culture of the strain ΔgaaB-Eg-Mg (PgaaA/C) in minimal
medium supplemented with CPW. Error bars represent ± SEM
(n = 3) and where not visible, are smaller than the symbol.including chemical and biochemical steps. This study is
the first report on an engineered filamentous fungus for
direct L-AA production. To the best of our knowledge,
the L-AA titer of 170 mg l−1 that was achieved in this
work is the highest among engineered fungal strains. In
addition, the pathway for L-AA biosynthesis originating
from D-galUA was for the first time introduced to a heter-
ologous host. In the previous literature, L-AA production
was reported to be achievable from D-glucuronic acid and
D-galUA using wild type strains of A. niger [22] or yeast
[23]. However, the detection method for L-AA that was
used in these studies (2,6-dichlorophenolindophenol
method) could not distinguish between L-AA and other
similar compounds, such as D-EA [24].
We decided to use the GALDH from M. glabra (acer-
ola), which is known for its vitamin C rich fruits, includ-
ing the native N-terminal mitochondrial signal peptide.
The kinetic parameters of MgGALDH are not known
but the expression level of MgGALDH is known to be
higher in M. glabra tissue when compared to the corre-
sponding GALDH gene (AtGALDH) expression in Ara-
bidopsis thaliana [25]. AtGALDH gene codes for a
protein having 75.25% homology with MgGALDH and
kinetic parameters of Km 0.17 mM and kcat 134 s
−1 for
L-galL [26]. We have also tested the expression of
AtGALDH gene in the A. niger ΔgaaB strain, however,
L-AA was not observed in the resulting strains (data not
shown). In plants, the GALDH locates on the inner
membrane of mitochondria binding non-covalently FAD
as a cofactor [26]. During the oxidation of L-galL to L-
AA, electrons are shuttled to cytochrome c and further
to the electron transport chain. The recombinant
AtGALDH without mitochondrial targeting signal has
been produced in E. coli as a cytoplasmic protein [26].
The resulting enzyme was active with L-galL when cyto-
chrome c was added to the reaction mixture. However, in
a living cell the functionality of a GALDH is probably
dependent on its correct localization enabling interaction
with mitochondrial cytochrome c. Thus it is crucial that
the mitochondrial targeting signal in a plant GALDH is
also functional in A. niger. Mitochondrial inner membrane
proteins are most often targeted to their location by an N-
terminal cleavable peptide [27]. The targeting peptide is
typically positively charged among different organisms.
However, in yeast, mitochondrial signal peptides are gen-
erally shorter, less alpha-helix forming and less hydropho-
bic when compared with the plant signal peptides [27].
The cleavage site for the signal peptides seem to be rela-
tively conserved between yeast and plants consisting of
tyrosine, leucine, phenylalanine and arginine residues [27].
In the case of AtGALDH and MgGALDH, the estimated
signal peptides differ being 102 and 84 residues long, re-
spectively [28]. The shorter signal peptide in MgGALDH
may be more suitable for mitochondrial targeting in A.
Kuivanen et al. Microbial Cell Factories  (2015) 14:2 Page 6 of 9niger, however, the localization of MgGALDH in the engi-
neered A. niger strains was not investigated in this study.
Despite several attempts, the ALase activity for L-galL
could not be detected from any of EgALase or smp30 ex-
pressing strains. In addition to A. niger strains, we have
also tried to express both of the ALases in yeast or
E. coli strains, however, without detectable activity. The
lactonase assay that was used in this work is based on a
pH change and a pH indicator in the reaction mixture.
The assay should provide high enough sensitivity for the
activity and it has been routinely and successfully used
in many studies. Consequently, the most likely explana-
tions for the non-detectable ALase activity are inactivity
of the protein in heterologous hosts or inactivation during
cell disruption. In the literature, EgALase was produced at
low temperature (15°C) in an E. coli strain co-expressing
the Trigger Factor chaperone protein [16]. In the case of
Smp30 from animal L-AA pathway, the recombinant pro-
tein was produced in E. coli co-expressing two chaperones
GroEL and GroES [17]. In addition, it has been reported
that production of human Smp30 protein in E. coli with-
out chaperones led up to the insoluble and inactive pro-
teins and formation of inclusion bodies [29,30]. Thus poor
folding of the ALase proteins in a heterologous host is a
possible explanation for the unsuccessful expression.
Regardless of the non-detectable ALase activity, sev-
eral A. niger strains with a functional GALDH were cap-
able of L-AA production. The lactonization reaction
might be spontaneous and may take place extracellularly.
In the lactonization reaction, protons are assimilated,
which mean that a low pH shifts the equilibrium to-
wards the lactone form. This would explain the fact that
only low pH enabled L-AA production. Thus it is pos-
sible that L-galA is first secreted out from the cells and
spontaneously formed L-galL is then transported back to
the cells and oxidized to L-AA. On the other hand, the
parental strain ΔgaaB is known for its higher capacity to
produce L-galA at low pH [19,20] which may provide
more substrate for the L-AA pathway also in the engi-
neered strains when cultured at low pH. The production
improved when CPW was used as substrate. In addition
to the higher fungal biomass in the inoculation, the im-
provement was possibly due to the additional carbon
sources that were constantly released from the substrate
during the fermentation providing energy such as redu-
cing power for the strain. The product titer was still rela-
tively low and possible limited by the poor lactonization
reaction from L-galA to L-galL. In addition, L-AA concen-
trations started to decrease during the fermentation. This
is likely due to the oxidation that occurs by the exposure
to air. Thus it would be beneficial for the process to
optimize factors, such as, aeration and timing of the har-
vesting. Nevertheless, this is the first demonstration of a
consolidated bioprocess for L-AA production.Conclusions
We have engineered A. niger strains to redirect the D-
galUA pathway to L-AA synthesis. The native catabolic D-
galUA pathway was disrupted and the biosynthetic L-AA
pathway from plants originating from D-galUA was intro-
duced. In addition, we built a strain having the L-AA path-
way under D-galUA inducible expression. The resulting
strains were capable of L-AA production from pure D-
galUA but also from CPW that is a pectin-rich biomass
residue. Final L-AA titers up to around 170 mg l−1 were
achieved with the engineered strains.
Methods
Strains
The Aspergillus niger strain ATCC 1015 (CBS 113.46)
was used as a wild type. The engineered strain of ATCC
1015 with the deleted L-galA dehydratase gaaB [19,20]
was used as a host strain for the L-AA production
strains that are listed in Table 1. All the plasmids were
produced in E. coli TOP10 cells and the homologous re-
combination for the plasmid construction was carried
out in the S. cerevisiae strain ATCC 90845.
Plasmid construction
For introducing the biosynthetic L-AA pathway in A. niger,
the heterologous genes coding for a GALDH or an ALase,
listed in Table 1, were custom synthetized as codon opti-
mized ORFs (Genscript) and inserted to the JKp1-hph plas-
mid [19] under the gpdA promoter. Alternatively, the
GALDH from Malpighia glabra (MgGALDH) and the
ALase from Euglena gracilis (EgALase) were both expressed
under the native bidirectional promoter (657 bp) of the A.
niger D-galUA reductase (gaaA) and the 2-keto-3-deoxy-L-
galactonate aldolase (gaaC) genes that are clustered in the
genome. In the expression cassette, MgGALDH was orien-
tated as gaaA and EgALase as gaaC in A. niger genome.
Terminators that were used in the bidirectional cassette for
MgGALDH and EgALase were the native gaaA and gaaC
terminators, respectively, both 505 bp downstream from
the stop codon. All of the expression cassettes contained
hygromycin B phosphotransferase (hph) gene under the
gpdA promoter for the selection of transformants.
The codon optimized ORFs were released with SacI and
XmaI (both NEB) and ligated to the JKp1 plasmid. The
resulting plasmids JKp1-EgALase/Smp30/MgGALDH were
linearized with SpeI (NEB). For constructing the cassette
with D-galUA inducible expression, the bidirectional gaaA/
C promoter and terminators of gaaA and gaaC genes were
amplified from A. niger ATCC1015 genomic DNA with the
primers P1-P6 as described in Table 2. The EgALase,
MgGALDH and the hph gene (from JKp1) were amplified
with the primers P7-P12 (Table 2). All the six amplified
fragments, containing 40 bp flanks for homologous recom-
bination, and an EcoRI and BamHI digested platform
Table 2 Primers used in this work
Primer Sequence Description
P1 AGGCATCTGTCTGAGAGGCAACCGTGGCGA Amplification of gaaA/C promoter, forward
GAGTCCGCATTCTTTGATCTGCTGTTAGTT
P2 GGTGACGAAGTGTGCGATTGAGCGTGATAA Amplification of gaaA/C promoter, reverse
AACGAAACATTGTGATTGCTGTGGTGTAAA
P3 TAAGTTGGAGAAGTTGTTTCCGTCGCTCGAT Amplification of gaaA terminator, forward
GCCATTTGAATACCTTAGAGAAGCTTGTATG
P4 CGTCTCTCCGCATGCCAGAAAGAGTCACCGG Amplification of gaaA terminator, reverse
TCACTGTACCATCTCCATCTCCTTCCCG
P5 GCCCCCCCTCGAGGTCGACGGTATCGATAAGC Amplification of gaaC terminator, forward
TTGATATCGAATTCCTGTTGGAGAGAGGGTGTGT
P6 CCCAGCCCCAGGTCCGCCACCCGCAGAGTTCCGT Amplification of gaaC terminator, reverse
TTGTGATCCATTGTATCATATAGATTATGAC
P7 ATGCGGACTCTCGCCACG Amplification of Eg ALase, forward
P8 TCACAAACGGAACTCTGCGG Amplification of Eg ALase, reverse
P9 ATGTTTCGTTTTATCACGCT Amplification of Mg GALDH, forward
P10 TCAAATGGCATCGAGCGAC Amplification of Mg GALDH, reverse
P11 GTACAGTGACCGGTGACTCT Amplification of hph, forward
P12 GCTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGA Amplification of hph, reverse
ACTAGTGGATCCTTGGAGATTTCAGTAACGTT















P28 CAACATTGTCATGTCTGGTGG qPCR of actin, forward
P29 GGAGGAGCAATGATCTTGAC qPCR of actin, reverse
P30 AGGACACGATTACTCTACTTG qPCR of gaaA, forward
P31 GAGCCCATATAATGGAAGTAC qPCR of gaaA, reverse
P32 TCCGGGTGGACCCCGCTAAG qPCR of EgALase, forward
P33 TGAAACACGGCTCCGGCGTC qPCR of EgALase, reverse
P34 TAGCAAGTGGCGCGGTGTCC qPCR of MgGALDH, forward
P35 TCGTGATCTCACCGCCCCGA qPCR of MgGALDH, reverse
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method [31] and the transformants were selected on SCD-
URA plates. Several yeast colonies were collected and the
resulting plasmid Bidir-EgALase-MgGALDH was rescued
and sequenced with the primers P13-P25 (Table 2). The
resulting expression cassette was linearized with EcoRI and
BamHI (both NEB) before A. niger was transformed.
All the resulting expression cassettes were introduced
into the A. niger ΔgaaB strain by protoplast transformation
method [32]. Transformants were screened for integration
of the cassette by growth in the presence of 400 μg ml−1
hygromycin B (Calbiochem). Strains having both genes
(smp30 or EgALase +MgGALDH) expressed in JKp1 under
gpdA promoter were generated by co-transformation. Inte-
gration of the transformed cassettes into the genome was
confirmed with colony PCR using Phire direct PCR kit
(Thermo Scientific) and the primers P26 and P27 (Table 2).
Media and culture conditions
Luria Broth (LB) culture medium supplemented with 100
μg ml−1 of ampicillin and cultural conditions of 37°C and
250 rpm were used for E. coli cultures. For yeast pre-
cultures, YPD medium (10 g yeast extract l−1, 20 g pep-
tone l−1 and 20 g D-glucose l−1) was used and after
transformation SCD-URA plates (uracil deficient syn-
thetic complete media supplemented with 20 g D-
glucose l−1) were used for uracil auxotrophy selection.
Yeast cultures were carried out at 30°C and all the li-
quid cultures at 250 rpm. For the A. niger submerged
fermentations, spores were generated on potato-
dextrose plates and 0.9*108 spores were inoculated into
50 ml of YP medium (10 g yeast extract l−1, 20 g
peptone l−1) containing 30 g gelatin l−1. Mycelia were
pre-grown in 250-ml Erlenmeyer flasks by incubating
overnight at 28°C, 200 rpm and harvested by vacuum
filtration, rinsed with sterile water and weighted. In the
A. niger transformations and fermentations, A. nidulans
defined minimal medium [33], containing (in g l−1) 6
NaNO3, 0.52 KCl, 0.52 MgCl2 and 1.52 KH2PO4 was
used. In the transformations the minimal medium was
supplemented with 1.2 M D-sorbitol, 10 g l−1 of D-
glucose and 20 g l−1 of agar and the pH was adjusted to
6.5. The minimal medium used in the fermentations for
L-AA production, enzymatic assays and transcriptional
analysis was supplemented with 20 g l−1 of D-galUA
and 5 g l−1 of D-xylose or with 40 g l−1 of dried citrus
processing waste (CPW). The pH was adjusted to 3. The
CPW contained peel and pulp from the processed or-
anges and was received from the Federal University of
Paraná in Curitiba, Brazil. The submerged cultures sup-
plemented with pure D-galUA and D-xylose were inoc-
ulated with 1 g l−1 (cdw) and the submerged cultures
supplemented with CPW were inoculated with 3 g l−1
(cdw) of pre-grown mycelia.Enzymatic assays
For enzymatic assays, A. niger mycelia were harvested by
vacuum filtration. Crude extracts were prepared in 100
mM sodium phosphate buffer pH 7 with protease inhibi-
tor (Complete, Roche). The cells were disrupted with 0.4
mm diameter glass beads using a bead beater (Precellys
24, Bertin Technologies) and solid residues were removed
by centrifugation. The GALDH assay was based on the
cytochrome c reduction at 550 nm as described by
Leferink et al. [26]. Crude extracts from the each strain
were supplemented with 500 μM of FAD (flavin adenine
dinucleotide), which is an essential cofactor for
MgGALDH, and were tested for the activity by follow-
ing the cytochrome c reduction after addition of 5 mM
L-galL. The enzymatic assay for the lactonase activity
(from EgALase and Smp30) was based on a pH change
in the reaction from L-galA to L-galL that absorbs protons
and was assayed as described by Ishikawa et al. [16]. The
pH was followed at 405 nm using p-nitrophenol as a pH
indicator and the correspondence between Δ405 nm and
the absorption of protons were quantified using the titra-
tion with HCl.
Transcriptional analysis
Samples of 2 ml were collected from the cultures and
the mycelium was harvested by vacuum filtration. The fil-
tered mycelium was frozen with liquid nitrogen and stored
at −80°C. RNA was extracted using the RNeasy Plant Mini
Kit (Qiagen) and ~1 μg of total RNA was used for cDNA
synthesis with the Transcriptor High Fidelity cDNA Synthe-
sis Kit (Roche), following the manufacturer’s instructions.
cDNA samples were diluted with RNase free water (Roche)
and were used for RT-qPCR using a LightCycler II with the
LightCycler SYBR green I Master mix (both Roche). The
expression of gaaA, EgALase, MgGALDH and actin (ATCC
1015 200483-mRNA) were quantified using the primers
P28-P35 (Table 2). The signal from each of the target genes
was normalized to actin using the accompanying software
(Advance Relative Quantification tool).
Chemical analyses
Samples of 2 ml were removed at intervals and mycelium
was separated from the supernatant by centrifugation. The
concentration of D-galUA and L-galA was determined by
HPLC using a Fast Acid Analysis Column (100 mm × 7.8
mm, BioRad Laboratories, Hercules, CA) linked to an Ami-
nex HPX-87H organic acid analysis column (300 mm × 7.8
mm, BioRad Laboratories) with 5.0 mM H2SO4 as eluent
and a flow rate of 0.5 ml min−1. The column was main-
tained at 55°C. Peaks were detected using a Waters 410 dif-
ferential refractometer and a Waters 2487 dual wavelength
UV (210 nm) detector. The L-AA content was measured
using the commercial Ascorbic Acid Assay Kit II (Sigma-
Aldrich) following the manufacturer’s instructions.
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